What Pharmaceutical Industry Should do to Adequately Implement a Quality Risk Management System

  • Speaker:Dr. David Lim
  • Duration:60Min
  • Product Code:GRC-90222

$279

refer

Refer Friend's


Live Session - How it works

  • Username and Password will be sent to you 24 hours prior to the webinar.
  • Presentation handouts in pdf format will be mailed to you.
  • Login to the session using the username and password provided to you.
  • Get answer to your queries through interactive Q&A sessions via chat.
  • Please let us know your thoughts and views at the end of webinar, your valuable feedback will help us improve.
  • Get certification of attendance.

Recorded Session - How it works

  • Login Information with Password to view the webinar, 24 hours after the Live webinar (link valid for 6 months).
  • A link will be provided to you upon purchase of the recorded session.
  • Please click on the link to access the session.
  • Presentation handouts in pdf format will be mailed to you.
  • Get certification of attendance.

Training CD - How it works

  • Free shipment within 72 Hours, from the date of webinar completion.

(More about our products contact +1- 248-233-2049)

If you are unable to attend the meeting Live then you can opt in for the Live Recording instead. You can access the recording of the webinar for 6 months. Contact our support for any clarifications. 

This presentation is intended to help you get familiar with best practices for quality risk management (QRM) applicable for pharmaceutical industry (drugs, biosimilars, and biologics).


This seminar is further intended to discuss how quality risk management can be effectively integrated into a quality system (QS) in the pharmaceutical industry.


This seminar will help attendees understand risk management principles, risk management tools, methods and processes applicable to the pharmaceutical industry.  In addition, this seminar will help the attendees how to develop and implement a systematic and holistic risk management strategy integrated into the quality system.


In this 60-min presentation, the speaker will guide you through the details of how to implement the systematic and holistic risk management for drugs, biosimilars and biologics.


Areas To Be Covered in this Seminar:

  • Applicable Laws and Regulations
  • Key Definitions
  • Risk Management (RM) Process – Systematic and Integrated
  • RM Principles
  • Risk Management Tools and Methods (PHA, HAZOP, HACCP, FTA, FMEA, FMECA)
  • Risk Ranking
  • How to Facilitate Quality Risk Management
  • Common Mistakes and How to Prevent Common Pitfalls
  • Risk Control Measures
  • Risk Communication – How
  • RM Applications for Operations, R&D, Materials, Facilities, Utilities, Equipment, Manufacturing, Labeling and Packaging, Laboratory Studies and Quality Control.
  • Doing RM Right Without Wasting Resources
  • Practical Aspects (Value) of Risk Management
  • Relationship with Other Quality Subsystems
  • Implementing RM in an Efficient and Effective Manner.
  • Speaker’s Practical PASS-IT Guide

Who will benefit:

  • CEOs
  • VPs
  • Compliance Officers
  • Attorneys
  • Complainant Managers
  • Managers (RA, QA/QC, CA)
  • Consultants
  • Contractors and Subcontractors
  • Anyone interested in the topic

Instructor Profile:

 

Dr. David Lim, Ph.D., RAC, ASQ-CQA.  Dr. Lim is President and Principal of Regulatory Doctor.  Dr. Lim frequently presents global regulatory and quality compliance topics in various forums and meetings.  Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past seven years.  Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009.  Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author and speaker.  Dr. Lim leads and directs all research projects including pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor.  

Available Options

Recording: Access the training Recording for 6 months from any location

$279

CD: Shipped within 2 working days

$389

5 Member Group: 5 can Attend Live Meeting Online from any location globally

$2,239

10 Member group: 10 can Attend Live Meeting Online from any location globally

$3,679

Related Products

510(K) Submission - A Comprehensive and an Updated Overview

510(K) Submission - A Comprehensive and an Updated Overview

If you are unable to attend the Live meeting then you can opt in for the Live Recording instead. You can access the recording of the webinar for 6 months. Contact our support for any clarifications. Why should you attend:The section [510(k)] of the Federal Food, Drug, and Cosmetic Act (FD&C Act or the Act) prescribes the premarket notification requirements. The premarket notification [510(k)] is the most common pathway to market for medical devices including in vitro diagnostic medical ..

$289

Implementing a (UDI) Unique Device Identification System

Implementing a (UDI) Unique Device Identification System

If you are unable to attend the meeting Live then you can opt in for the Live Recording instead. You can access the recording of the webinar for 6 months. Contact our support for any clarifications. Description: This webinar will discuss the regulatory and compliance requirements to implement a system for Unique Device Identification (UDI) including final rules, compliance dates and requirements. The speaker will walk you through the requirements including, but not limited to, what to con..

$279

Understanding the US FDA Drug Review and Approval Process

Understanding the US FDA Drug Review and Approval Process

We offer face to face in person seminar for companies/ corporate. Contact our support to set up a date and price. Why should you attend: The FDA’s Center for Drug Evaluation and Research (CDER) is responsible for reviewing and approving both prescription and nonprescription or over-the-counter (OTC) drugs. To introduce a new drug product into the U.S. market, some firms submit a new drug application (NDA) to the US FDA/CDER. The firms are responsible for testing a drug and for sub..

$279

FDA's GMP Expectations for Phase I and First-In-Man Clinical Trials

FDA's GMP Expectations for Phase I and First-In-Man Clinical Trials

If you are unable to attend the Live meeting then you can opt in for the Live Recording instead. You can access the recording of the webinar for 6 months. Contact our support for any clarifications. Why you should attend:Attend this conference so that you may understand differences between GMP requirements for early and later stage clinical development.  Explore and discuss ways to develop and implement strategies for your GMP documentation.What is the topic about:This webinar will rev..

$289

Auditing Quality Suppliers and Vendors

Auditing Quality Suppliers and Vendors

If you are unable to attend the meeting Live then you can opt in for the Live Recording instead. Access the recording of the webinar for 6 months. Contact our support for any questions. To prepare an invoice to pay by Check or Wire email us at support@grcts.com. Description:The various regulatory agencies have expectations that pharmaceutical manufacturers will demonstrate control over their manufacturing processes, validations, and documentation. Quality auditing is the process of checking..

$269